Psoriasis Drugs Market By Therapeutic Class (Tumor Necrosis Factor-inhibitors, Interleukin-inhibitors, Vitamin D analogues), By Treatment (Topicals, Systemic, and Biologics), By Type (Plaque Psoriasis, Psoriatic Arthritis and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region - Trends, Analysis and Forecast till 2030

Report Code: PMI7018 | Publish Date: June 2023 | No. of Pages: 170

Global Psoriasis Drugs Market Market Companies

  • AbbVie, Inc.
  • Pfizer Inc.
  • Novartis
  • Eli Lilly and Company
  • Johnson & Johnson
  • Celgene Corporation
  • Amgen Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co Inc.
  • Janssen Biotech Inc.

Recent News:

  • Dermavant released the first streaming advertisement for "Vtama," a new topical skin medication for psoriasis, in November 2022. Its first streaming ad, which targets adults with plaque psoriasis, was just released as part of a multimedia campaign. Along with the radio and other social media channels, the streaming video will be available on multimedia platforms like Roku, YouTube, and Paramount.
  • The US FDA approved Bristol Myers Squibb's new medication, Sotyktu, or deucravactinib, in September 2022 for use as an oral treatment for adults with moderate to severe plaque psoriasis. Sotyktu is the first of its kind and is a recently approved oral selective TYK2 (tyrosine kinase 2) inhibitor.